Compile Data Set for Download or QSAR
Report error Found 33 Enz. Inhib. hit(s) with all data for entry = 50007978
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514606(CHEMBL4517539)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514614(CHEMBL4533779)
Affinity DataIC50: 4.30nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514621(CHEMBL4443475)
Affinity DataIC50: 4.5nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514615(CHEMBL4520765)
Affinity DataIC50: 4.80nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514603(CHEMBL4550298)
Affinity DataIC50: 5.40nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514623(CHEMBL4457477)
Affinity DataIC50: 5.60nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514613(CHEMBL4459934)
Affinity DataIC50: 6.40nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514603(CHEMBL4550298)
Affinity DataIC50: 7.90nMAssay Description:Inhibition of IDO1 in IFN-gamma stimulated human HeLa cells assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514625(CHEMBL4521139)
Affinity DataIC50: 8.70nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514620(CHEMBL4529084)
Affinity DataIC50: 9nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514630(CHEMBL4463872)
Affinity DataIC50: 12nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514631(CHEMBL4456038)
Affinity DataIC50: 14nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514632(CHEMBL4448431)
Affinity DataIC50: 17nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514617(CHEMBL4447760)
Affinity DataIC50: 17nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514624(CHEMBL4476353)
Affinity DataIC50: 19nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514612(CHEMBL4475838)
Affinity DataIC50: 19nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514626(CHEMBL4474052)
Affinity DataIC50: 21nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514618(CHEMBL4541737)
Affinity DataIC50: 22nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514608(CHEMBL4467532)
Affinity DataIC50: 36nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514616(CHEMBL4483789)
Affinity DataIC50: 36nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514628(CHEMBL4442192)
Affinity DataIC50: 37nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514629(CHEMBL4529203)
Affinity DataIC50: 45nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514611(CHEMBL4543807)
Affinity DataIC50: 52nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514604(CHEMBL4441700)
Affinity DataIC50: 56nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514603(CHEMBL4550298)
Affinity DataIC50: 66nMAssay Description:Inhibition of recombinant 6His/FLAG/Avi-tagged/Tev-fused IDO1 holoenzyme (unknown origin) expressed in Escherichia coli BL21 (DE3) using D-TRP as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514619(CHEMBL4451215)
Affinity DataIC50: 99nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514605(CHEMBL4460190)
Affinity DataIC50: 107nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514627(CHEMBL4594031)
Affinity DataIC50: 152nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514622(CHEMBL4518978)
Affinity DataIC50: 219nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514607(CHEMBL4513476)
Affinity DataIC50: 251nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514609(CHEMBL4568125)
Affinity DataIC50: 3.81E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514610(CHEMBL4579256)
Affinity DataIC50: 5.62E+3nMAssay Description:Inhibition of IDO1 in IFN-gamma/LPS stimulated human PBMC assessed as reduction in kynurenine production after 48 hrs by RapidFire MS assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetIndoleamine 2,3-dioxygenase 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50514603(CHEMBL4550298)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant 6His/FLAG/Avi-tagged/Tev-fused IDO1 holoenzyme (unknown origin) expressed in Escherichia coli BL21 (DE3) using D-TRP as sub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed